Twitter: @mravenEM.
INTRODUCTION
Despite some evidence to the contrary, 1 many policymakers, health care providers, and other stakeholders believe a substantial number of emergency department (ED) visits could be avoided or conducted in less costly alternative settings. 2 Payers have tried various means to discourage the use of EDs and to encourage the use of non-ED settings, such as primary care and retail clinics, in accordance with a belief that this will result in health care savings. 3 Nationwide, there are many programs to reduce ED visits. 4, 5 Some deploy intensive management to address social and medical needs for a small group of high-risk individuals who contribute to a large number of ED encounters. Others aim to decrease ED use broadly across a large population with low-acuity visits. ED visits are often perceived as costly and unnecessary, increasing pressure from payers such as Medicaid to reduce them. 6, 7 The effectiveness of these programs is poorly understood. There have been 4 published reviews that have focused on a specific program type or target population (eg, frequent ED users, case management programs). Each review concluded that the majority of programs reduced ED use. However, none applied a quality assessment in advance to determine which studies to include. As a result, the published systematic reviews include low-quality studies, which could undermine the validity of conclusions about program effectiveness. In addition, none included research published after 2010. [8] [9] [10] [11] It is possible that including research studies conducted since 2010 and restricting the review to moderate-and high-quality studies would lead to different conclusions.
Attempts to reduce ED use may be logically sound, but it is unclear whether strategies to pursue ED visit reduction are effective and without adverse consequences. We conducted a systematic review of published moderate-and 
Editor's Capsule Summary
What is already known on this topic Many different interventions have been tested to reduce emergency department (ED) utilization among frequent or low-acuity users, with mixed results.
What question this study addressed
The authors reviewed the effectiveness of ED reduction programs but limited their evaluation to studies of moderate to high quality.
What this study adds to our knowledge Less than one third of ED reduction programs were moderate to high quality. A diverse set of interventions and patient populations was examined. Only case management was found to reduce frequent ED use, and this evidence was based on 3 small studies.
How this is relevant to clinical practice
High-quality studies on this topic are needed; there is no need for more poorly conducted studies.
high-quality peer-reviewed studies of ED visit reduction programs between 2003 and 2015 that sought to reduce adult ED visits in the United States. The objective of our systematic review was to determine whether specific types of ED visit reduction programs are effective in reducing ED visits and result in adverse events. Our assessment was limited to those studies we judged to be of moderate or high quality by Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria.
MATERIALS AND METHODS
We report our systematic review according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. 12 We submitted our formal review protocol to PROSPERO, including search strategy, primary outcomes, and study inclusion and exclusion criteria.
Study Design
We conducted a systematic literature search of PubMed, CINAHL, and PsycINFO for studies published between 2003 and 2014. Our search strategy included 1 main search term, "ED use." For this search term, we combined the Medical Subject Headings terms "emergency service, hospitalization/utilization," (CINAHL) "emergency service/utilization," "emergency care/utilization," and "emergency medical services," and (PsycINFO) "emergency medical services, hospital, and utilization." Using the Boolean "and" operator, we combined these subject heading terms with search terms related to "high frequency or high risk" and then with terms related to "low acuity." We then combined these results with terms that reference programs designed to reduce visits. Finally, we performed supplemental searches with terms used in previous reviews, related to programs or interventions designed to reduce ED utilization (Table 1) .
We focused on studies published from 2003 to 2014 because during this period, rapid increases in ED utilization motivated an increasing number of interventions to decrease ED use, and because studies conducted in this period are relevant for practice today. We did not consider gray literature for this review after our initial scan demonstrated it did not meet the quality criteria outlined below.
Data Collection and Processing
We limited the scope of our review to studies of programs with a stated intent to reduce ED visits, which had ED visit reduction as a prespecified study outcome. We included randomized controlled trials and observational studies of programs published in the peer-reviewed literature that reported changes in ED visits as a discrete outcome. We included studies only from the United States because results from other countries may not be comparable because of differences in health care delivery and payment systems. We targeted studies that included adults either exclusively or in combination with children and excluded those that focused only on children. We excluded studies that reported ED use only as an aggregate outcome in combination with other health services use, did not include an abstract, and were not written in English. We included programs that focused on visits to medical EDs for mental health complaints but excluded those that focused exclusively on visits to psychiatric EDs because the patients who visit them and the care they deliver are distinct from those of nonpsychiatric EDs.
We decided a priori that several types of delivery system interventions whose primary purpose was not to reduce ED utilization were out of this review's scope. This included chronic disease management programs whose primary goal was to avoid hospital readmissions, patient-centered medical homes, electronic medical records, and clinical treatment studies (unless such studies were directly related to ED management and designed to reduce ED visits). Although we did include ED visit reduction programs whose target population included active substance users, we excluded studies of programs in which the primary goal was substance use treatment and not ED visit reduction. Similarly, we excluded criminal justice system diversion programs because the primary goal of such programs is diversion out of the criminal justice system, not ED visit reduction. We excluded programs that focused on transitions of care from hospital to home because such programs have avoidance of hospital readmissions as their primary goal. We considered programs that focused on nonmedical issues associated with ED use and hospitalizations, such as permanent supportive housing and medical respite care for homeless individuals, outside of our scope.
One primary reviewer (M.J.K.) screened study titles for inclusion and exclusion criteria ( Figure E1 , available online at http://www.annemergmed.com). After the title screen, we selected a 10% random sample of abstracts, and 2 reviewers (M.J.K. and J.P.) screened abstracts for potential inclusion ( Figure E1 , available online at http://www. annemergmed.com). Once we confirmed satisfactory interrater reliability (k>0.7), the primary reviewer (M.J.K.) screened the remaining abstracts to select articles for further evaluation. We followed a similar process with the selected articles. Two reviewers (M.J.K. and JP) screened a 20% random sample of the selected full articles (n¼159) ( Figure E1 , available online at http://www.annemergmed.com), and after we confirmed satisfactory interrater reliability (k>0.7), the primary reviewer (M.J.K.) appraised the remaining potentially eligible articles for inclusion.
From all eligible studies, we extracted program title; geographic location; intervention type; target population; study design and methods; participant enrollment; program setting, including whether studies occurred at a single site or multiple (>1) sites; program duration; effect on ED use; effect on non-ED health care use; and financial data related to program costs and savings.
We classified studies into one of 2 distinct categories: those directed at high-risk populations and those directed at low-acuity visits. High-risk programs aimed to reduce ED use in high-risk populations including individuals who were frequent users of ED services or who possessed characteristics of those who were likely to become frequent users of ED services. Low-acuity programs aimed to reduce "low-acuity" ED visits that were not "emergency" in nature and could in theory be managed safely in a non-ED setting.
Within these 2 categories, we separated studies into multiple program subtypes. We based the subtypes on an existing taxonomy proposed by Morgan et al 9 and created additional program subtypes when studies of programs did not fit into that framework. We identified 7 subtypes "Emergency Service/utilization," "Emergency Care/utilization," and "Emergency Medical Services," and (PsycINFO) "emergency medical services, hospital, and utilization" Secondary search High frequency/high risk "frequent use" "frequent flyer" "high risk" "high use" "frequent attendee" "heavy use" "repeater" "recidivist" "revolving door" "repeat visits" "repeated visits" Low acuity "non-urgent" "non-emergent" "non-emergency" "overuse" "low acuity" "misuse" "inappropriate use" "ambulatory care sensitive" "avoidable" "preventable" Terms that reference programs or interventions designed to reduce visits "intervention" "program" "protocol" "initiative" "project" "reduction" "reduce*" "decrease*" "decline*" "cut back" "lessen" "eliminate*" Terms specific to program types ED diversion: "diversion" "triage" "call lines" Patient education: "patient education" as subject heading Alternative site expansion: "extended hours" "after hours" "clinic expansion" "mobile clinic" "same-day appointment" "next-day appointment" "urgent care clinic" "added sites" "additional sites" "new sites" "new clinics" "urgent care" "retail clinic" retail care" Linkages to primary care/care coordination: "care coordination" "care integration" "primary care access" "primary care referral" "primary care follow-up" "primary care appointment" Health technology: "electronic health record" "electronic medical record" "health information technology" "data sharing" "electronic information sharing" Financial incentives: "cost-sharing" "cost share" "co-pay" "co-payment" "managed care" "bundled payment"
"out-of-pocket" "shared saving" Case management: "case management" "brokerage" "social worker" "case worker" "case manager"
"case coordinator" "case coordination" Health/social service navigation/care coordination: "navigator" "navigation" Pain management: "pain management" "pain control" "chronic pain" "opioid seeking" "opiate seeking"
"opioid prescription" "opiate prescription" "opiate prescribing" "opioid prescribing" "fraud" "opioid dependence" Ambulatory ICUs: "ambulatory intensive care" "outpatient intensive care" "outpatient observation unit" related to high-risk populations and 3 related to low-acuity ED visits (Figure 1) .
After data collection, we used the GRADE criteria system to rate the quality of individual studies of ED visit reduction programs. 13 We restricted our analysis to studies we rated as either moderate or high quality according to GRADE. Two reviewers (M.J.K. and J.P.) examined each eligible study for quality grading ( Figure E1 , available online at http://www.annemergmed.com). We assessed the methodological quality of studies independently from the study findings and included studies with both positive findings (evidence for ED visit reductions) and negative ones (no evidence for ED visit reductions, or evidence for increases in ED visit rates). Under the GRADE system, studies are assigned an initial 4-point scale ranging from very low to high quality according to study design ( Figure 2 ). We assigned an initial high rating to randomized controlled trials and an initial rating of moderate to studies with a nonrandomized but equivalent comparison group, in which there would be limited systematic bias in selection for the intervention group; and quasi-experimental studies with a nonequivalent comparison group, with rigorous statistical methods applied to adjust for confounding between groups. We assigned an initial rating of low to all other study types. After the initial rating assignment, we divided studies into 2 sets: initial high-or moderate-quality and initial low-quality studies. For each set, 2 reviewers evaluated each study according to 3 criteria that could result in a quality rating downgrade (with "very low" as the lowest possible grade) and 3 criteria that could result in an upgrade (to a maximum of "high"). Criteria used to downgrade evidence were risk of bias or study limitations, imprecision, and publication bias. The indicators for rating evidence upward were having a large magnitude of effect, having a dose-response gradient, and having plausible unobserved confounders that would minimize the observed effect, therefore making it likely that the magnitude of effect could be larger than reported (see Table E1 , available online at http://www.annemergmed.com, for additional details). We compared ratings between reviewers (M.J.K. and J.P.) to assess interrater reliability (k>0.7). We considered the 2 initial reviewers to have reached consensus if their GRADE scores matched (eg, moderate and moderate, low and low). In instances of disagreement, a third reviewer (M.C.R.) also assigned a rating and then convened a meeting of all 3 reviewers to achieve consensus.
Primary Data Analysis
We describe studies we excluded in Table E2 , available online at http://www.annemergmed.com. The small number of moderate-or high-quality studies included in our review had a high level of heterogeneity in terms of program type and outcomes reporting, which limited our ability to conduct a meta-analysis. Instead, we created evidence tables to display study characteristics and results, organized first by program category (high risk versus low acuity) and then by program subtype (Figure 1) . We analyzed studies within each program subtype to compare intervention characteristics, study methods, and outcomes. We used GRADE ratings to develop recommendations about the overall quality of the evidence for each program subtype.
Outcome Measures
Our primary outcome of interest was ED utilization. Secondary outcomes included adverse events, defined as hospital admissions and mortality. We defined adverse events as increases in hospital admissions or mortality because ED visit reduction programs could have resulted in increased hospital admissions or mortality if, by discouraging ED use, they caused individuals to delay seeking treatment. We had planned to examine the costeffectiveness of the programs in our review, but there were insufficient data to evaluate it.
RESULTS
We evaluated the quality of 38 studies of ED visit reduction programs (Table 2) . Of the 38 studies, we rated 13 as moderate to high quality according to GRADE criteria and included them in this review; 4 were evaluations of programs targeted toward high-risk populations and 9 targeted low-acuity visits (Tables 3 and  4 ). We assigned low or very low quality ratings to the 25 studies excluded from our review (Table E2 , available online at http://www.annemergmed.com) for combinations of the following reasons: lack of a comparison group (18 studies); surveillance of outcomes at only a single site (14 studies); insufficient statistical testing (6 studies); small sample size, ranging from 10 to 26 participants (5 studies); use of a nonequivalent comparison group (5 studies); and outcomes based on short or different follow-up periods between intervention and comparison groups (3 studies).
There were 3 studies that evaluated the effect of case management for high-risk patients with frequent use of the ED. [39] [40] [41] The interventions targeted people with at least 5 ED visits in the past year 39, 41 or fewer than 5 ED visits combined with multiple hospital admissions in the past year. 40 In all 3 interventions, case managers provided intensive direct services within the ED, hospital, and community by frequent, in-person contact with patients. All 3 studies showed a statistically significant reduction in ED visits. One study reported consistently fewer ED visits Chronic non-cancer pain management: Programs involve switching participants to non-opioid treatment regimens provided in the ED, and care coordination with primary care providers to reinforce use of non-opioid treatments.
Health technology and information sharing:
Programs use electronic medical records (EMR) to identify frequent ED users. Multidisciplinary care teams develop individualized care plans for each frequent utilizer, and the care plans are uploaded into the EMR and available to treating providers upon repeat visits. The teams update care plans on a regular basis.
Patient education:
This program type includes broadly implemented patient educational programs providing instruction about appropriate use of the ED either in general, or for specific conditions. Ambulatory Intensive Care Units (AICUs): AICUs deliver care similar to intensive case management programs in terms of high-risk patient selection and deployment of a multidisciplinary team to address patient needs in multiple health and social domains. Yet while case management programs tend to use a social model of care, AICUs function on a medical model, with nurses at the center, focusing on optimizing medical treatment.
Low Acuity Visit Program Types
Primary care linkage: Programs are aimed at reducing low acuity ED use by strengthening linkages to primary care and/or providing care coordination. These efforts are typically conducted in the ED during a visit, or shortly after an ED visit.
ED Diversion: Programs aim to direct patients with away from the ED, either before or at the time of ED triage. These programs can occur by directing ED patients to onsite urgent or primary care clinics, or can occur during an encounter with EMS prior to ED arrival. among intervention patients in each 6-month period after enrollment, up to 24 months. 39 The second reported a 32% lower risk of ED visits during 1 year compared with that for controls, 40 and the third reported 12.1 fewer ED visits during 6 months compared with that for prospective controls and 12.8 fewer ED visits during 6 months compared with that for historical controls. 41 None of the studies found an increase hospital admission rates beyond what would have been expected. The single study that examined mortality differences found higher rates of death among nonparticipants (zero in the intervention group, 2 in the prospective control group, and 7 in the historical control group). 41 One randomized controlled trial assigned adult and pediatric patients 1:1 to usual care or a comprehensive asthma education program intervention. 42 To be eligible, participants were required to have a diagnosis of moderate to severe asthma and to have had at least 1 ED visit in the previous year. The intervention consisted of a telephone call from an asthma nurse educator 3 to 5 days after the ED visit, who arranged and attended a primary care provider follow-up visit and created an asthma care plan for the patient. This nurse conducted a home visit 6 weeks later to evaluate environmental triggers and to review the care plan. Authors found a nonsignificant reduction in ED visits at 6-month follow-up in the intervention group compared with controls (23.1% versus 31.1%) and did not assess hospitalizations or mortality in the intervention or control groups.
We found 3 randomized controlled trials of programs for patients with low-acuity complaints that involved linkage to primary care physicians at or close to ED discharge. [43] [44] [45] Each study targeted different patient populations. One study found evidence for reductions and 2 others did not. One study randomized 43 health plan members with an ED discharge diagnosis of a primary anxiety disorder 1:1 to a telephone-based intervention. Investigators reported statistically significant reductions at 6 months for ED visits with psychiatric diagnoses, comparing intervention participants to controls (0.26 visits versus 0.39 visits, respectively), and did not examine hospital admission rates or mortality.
The second randomized controlled trial targeted ED patients aged 65 years and older who were expected to be discharged from the ED. Patients randomized to the intervention met with a geriatric nurse, who conducted a needs assessment during the ED visit, sent a summary to the patient's primary care provider, and conducted telephone follow-up to encourage the primary care provider visit. Investigators found no difference in the percentage of participants who made repeated ED visits within 120 days compared with controls (37% versus 40%) and found no differences in hospitalizations (28% versus 27%). 44 The study did not evaluate mortality.
A third randomized controlled trial targeted uninsured patients with no primary care provider. Patients were randomized 1:1 during an ED visit, and investigators evaluated the effect of using ED-based health promotion "advocates" to help patients choose a primary care provider during the visit and then faxed the patients' information to the chosen primary care provider. Advocates contacted patients after the visit in person or over the telephone to help schedule a primary care provider appointment and to connect patients to other community-based services. Study investigators followed patients for 6 months after enrollment. Investigators comparing intervention and control groups found no difference in the probability of an ED visit (relative risk 1.07; 95% confidence interval 0.72 to 1.58) or hospitalization (relatve risk 0.39; 95% confidence interval 0.10 to 1.46) and did not assess mortality.
45
One quasi-experimental trial examined a post-ED triage diversion program for ED patients with low-acuity complaints. Investigators referred eligible patients to an onsite primary care clinic (intervention) or to an ED-based urgent care clinic (usual care) according to which site (urgent care versus onsite primary care) would result in the least delay. 46 A secondary comparison group included ED patients who met eligibility criteria but who had a primary care provider outside the study hospital. The study found no reductions in ED visits at 12-month follow-up comparing intervention to usual care groups (adjusted mean difference -0.23; 95% confidence interval -0.61 to 0.16) and did not assess hospitalization rates or mortality. 46 Five studies examined the effect that imposing ED copayments at the visit had on ED use. The largest study examined the effect of ED copayments for Kaiser Permanente members with Medicare or commercial insurance. 47 Another study evaluated a program for individuals enrolled in commercial insurance through their employer. 48 Three studies were of copayments implemented by state Medicaid programs. [49] [50] [51] Three of the 5 studies-1 within Kaiser and 2 studies of copayments implemented within the Oregon state Medicaid program-reported significant reductions in ED visits. The Kaiser study found that ED visit rates decreased with increasing copayment levels (adjusted relative rate $1 to $5: 0.962 [95% CI 0.955-0.970] up to $50 to $100: 0.765 [95% CI 0.756-0.774]). The 2 studies of $50 ED copayments within Oregon Medicaid (which also implemented $5 copayments for primary care visits and $250 copayments for hospital admissions) found ED visit reductions of 18.0% and 7.9%, 50 respectively. 49 The 2 additional studies found no difference when comparing intervention and control groups.
Three studies examined programs' effect on hospitalizations. The Kaiser study found significant decreases for commercially insured subgroups (4% for $20 to $35 copayments; 10% for $50 to $100 copayments) and no difference among Medicare beneficiaries. One of the 2 Oregon Medicaid studies 50 examined inpatient hospital admissions and found they were significantly decreased, by 27.3%, whereas the other found that ED-based hospital admissions were reduced by 24.0%. 49 The remaining 2 studies did not evaluate program effect on inpatient hospital admissions. The study within Kaiser was the only one to evaluate mortality and found no difference in relative mortality rates among Kaiser members with and without copayments.
LIMITATIONS
Our study has several limitations. Program terminology varied widely across the studies included in our review. Terms such as "low-acuity" or "frequent ED user" were defined differently across studies. We grouped studies that used similar definitions into similar program types and subtypes to minimize these differences. We found variations in how target populations were identified, how programs were staffed, how outcomes were measured, and how programs defined success or failure. This lack of 
DISCUSSION
We found that several types of ED visit reduction programs exist, and our typology may be useful to standardize future research in this area. In contrast to previous reviews of ED visit reduction programs, [8] [9] [10] [11] we limited our review to studies of ED visit reduction programs that were moderate to high quality. Health care payers and policymakers are interested in implementing ED visit reduction programs to achieve cost savings while maintaining or improving quality, and many states and large foundations have invested in these efforts. 2, 52 The small number of studies that qualified for our review highlights a lack of evidence about program effectiveness. In addition, even among the studies we categorized as moderate to high quality, most were moderate quality and very few were randomized controlled trials. As a result, some of the inconsistencies we found in study results could reflect inadequate rigor of program evaluation study designs.
Among studies of programs focused on high-risk patients, we found evidence for the effectiveness of case management in reducing ED use among high-risk patients. [39] [40] [41] Although the collective findings of the case management studies we included in our review suggest that they are effective in reducing ED use for high-risk populations, stronger evidence is needed about program cost-effectiveness, given the intensive resources required for such interventions. A review of ED visit reduction programs by Althaus et al 10 that focused on frequent ED users concluded that case management interventions reduced ED costs. In contrast, we found that only 5 of the 13 studies we reviewed reported data on health care costs, 39, 40, 43, 44, 50 and these data were insufficient to draw valid conclusions. Data on the financial influence of ED visit reduction programs will be essential for future research.
We rated the majority of studies focused on programs targeting high-risk individuals as low and very low quality because there was no equivalent comparison group (Table E2 , available online at http://www.annemergmed. com). Regression to the mean can bias the results of programs focused on reducing ED use among frequent ED users toward a treatment effect if no comparison group is identified and will prevent policymakers from drawing valid conclusions. Among the studies of programs focused on reducing lowacuity ED visits, only ED visit copayments resulted in significant ED visit reductions, although there were conflicting results among the studies of ED visit copayments for Medicaid beneficiaries. A multistate Medicaid study reported no difference in ED use among beneficiaries in states with and without ED visit copayments, even though a separate study that focused on one of the states (Oregon) found ED visit copayments to be effective in reducing ED visits. The difference in the findings between the multistate study and the Oregon study may be attributable to the size of the ED visit copayments. In most states, copayments range from $2 to $8 per ED visit for Medicaid beneficiaries, but in Oregon they were $50. In contrast to other intervention types that require hiring dedicated staff, ED copayment programs are largely administrative and thus low cost, and can be implemented quickly across a large insured population. However, imposing penalties for ED use could result in delays in needed care, especially for low-income populations, who often lack timely access to outpatient care. 53, 54 A previous review of care coordination interventions by Katz et al 8 concluded that ED-based care coordination interventions, most of which involve interfacing or referring to outpatient primary care providers, were effective. The quasi-experimental studies included in that review were more likely to find that an intervention reduced ED visits compared with higher-quality, randomized controlled trial study designs. Although the scope of our program types included in our review was slightly different than that of Katz et al, we did not find evidence that strategies that attempt to reduce ED use by expanding primary care hours or initiating linkages to primary care for patients in the ED are successful in reducing ED visits. [41] [42] [43] [44] Many ED visit reduction programs assume that primary care can serve as a lowercost substitute and reduce overall demand for ED care. 55 Yet there is also evidence that the ED may be serving as a safety net for an overburdened primary care system. 56 Recent research by RAND 57 indicates that primary care providers may be relying on the ED to initiate evaluations that are not feasible in an outpatient setting.
We did not address new models of primary care delivery, such as that delivered through patient-centered medical homes, which provide panel management, more on-demand services for patients such as same-day appointments, and a higher level of care management and care coordination than what is delivered in a traditional primary care practice. 58 It is possible that although ED visit reduction is not their primary goal, enhanced primary care practices could be effective in reducing the use of ED services, decreasing health care costs, and improving patient outcomes. 59 There is widespread policy interest in reducing ED visits; this interest has driven the development of programs that seek to decrease ED use. However, moderate-to highquality studies that examine ED visit reduction programs in the peer-reviewed literature are limited, and our review, when limited to studies of moderate to high quality, arrived at conclusions different from those of previous reviews. Case management for high-risk individuals is the only intervention that the literature has found to consistently reduce ED visits. ED visit copayment has been found repeatedly but not always to be effective in reducing ED visits; its effectiveness may in part be related to the size of the copayment. The data on the costs of ED visit reduction programs are insufficient to determine whether any of these programs are cost-effective. Therefore, it would be appropriate to continue to regard ED visit reduction programs other than case management programs as demonstrations rather than proven interventions and to pursue evaluations that overcome the limitations we have highlighted in the existing peer-reviewed literature.
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